Optimum Dose of Once-Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double-Blind Trial Versus Placebo

2015 ◽  
Vol 8 (3) ◽  
pp. 150-158 ◽  
Author(s):  
Osamu YAMAGUCHI ◽  
Eiji UCHIDA ◽  
Naruhito HIGO ◽  
Hidenao MINAMI ◽  
Shigeo KOBAYASHI ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Japanese Patients ◽  
Optimum Dose ◽  
Double Blind Trial ◽  
Double Blind ◽  
Once Daily ◽  
Blind Trial

scholarly journals Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial

2013 ◽  
Vol 21 (6) ◽  
pp. 586-593 ◽  
Author(s):  
Osamu Yamaguchi ◽  
Eiji Uchida ◽  
Naruhito Higo ◽  
Hidenao Minami ◽  
Shigeo Kobayashi ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Japanese Patients ◽  
Double Blind Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Once Daily ◽  
Blind Trial

Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE)

2013 ◽  
Vol 111 (5) ◽  
pp. 804-810 ◽  
Author(s):  
Linda Cardozo ◽  
Gerard Amarenco ◽  
Dmitry Pushkar ◽  
Jura Mikulas ◽  
Ted Drogendijk ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Dose Escalation ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Overactive Bladder Symptoms ◽  
Bladder Symptoms
Sign in / Sign up

Export Citation Format

Share Document